MARINA MESSINGER M.D. NPI 1902192677

NPI Details

Marina Messinger, M.D. is an internal medicine in Rolling Meadows, IL with 14 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Marina Messinger, M.D. NPI is 1902192677. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Graduation Year:2011

The provider's business location address is:

3701 ALGONQUIN RD STE 900
ROLLING MEADOWS, IL
ZIP 60008-193
Phone: (847) 577-0620

The NPI 1902192677 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Magnesium level (HCPCS:83735)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Folic acid level, serum (HCPCS:82746)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Urinalysis, manual test (HCPCS:81002)
• Phosphate level (HCPCS:84100)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 6/21/2011 and was last updated on 7/21/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: